Most Recent
A judge has signed off on the lead applicants' bid to expand the current group definition in a class action against Johnson & Johnson unit Ethicon over allegedly defective vaginal mesh products, saying there was "no reason in logic" why the request should be denied.
Apple founder Steve Jobs' penchant for using the phrase "One more thing" as a rhetorical flourish during his highly anticipated "Stevenote" talks -- usually before unveiling a new Apple product -- does not constitute a trade mark use, according to a decision quashing Apple's opposition to watch maker's Swatch' application to trade mark the phrase in Australia.
Former Aussie Home Loans boss Stephen Porges has lost an appeal of a judgment ordering him to pay more than $1 million to a private equity firm that was found to have been duped into buying his worthless shares in a beleaguered startup.
James Cook University unlawfully dismissed a professor who spoke out against the school and one of its scientists over its climate change views, a judge found Tuesday.
Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.
Racing Victoria has dragged fantasy sports gambling company PlayUp to court for allegedly infringing its 'Best Bets' trade marks.
Accounting giant Deloitte has failed in its bid to strike out claims made in two shareholder class actions alleging it was careless in auditing the financial statements of electronics retailer Dick Smith ahead of its collapse in 2016.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court's decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
Telecom giant Optus has been hit with a $25,000 criminal fine after pleading guilty to four charges of failing to disclose political donations in its development applications.
An argument over the admissibility of an expert report produced by the Australian Securities and Investments Commission in its insurance churn case against AMP was sidestepped Monday, with a judge proposing experts from both sides instead file a joint report in the case.